GOCO Quote, Financials, Valuation and Earnings

CorVel has a net margin of 5.73% compared to GoHealth's net margin of 10.43%. GoHealth's return on equity of -6.99% beat CorVel's return on equity of 32.6%.

GoHealth has a consensus price target of --, signalling upside risk potential of 41.83%. On the other hand CorVel has an analysts' consensus of -- which suggests that it could fall by --. Given that GoHealth has higher upside potential than CorVel, analysts believe GoHealth is more attractive than CorVel.

GoHealth has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CorVel has a beta of 1.139, suggesting its more volatile than the S&P 500 by 13.888%.

GoHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CorVel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoHealth pays -5.64% of its earnings as a dividend. CorVel pays out -- of its earnings as a dividend.

GoHealth quarterly revenues are $118.3M, which are smaller than CorVel quarterly revenues of $224.4M. GoHealth's net income of $6.8M is lower than CorVel's net income of $23.4M. Notably, GoHealth's price-to-earnings ratio is -- while CorVel's PE ratio is 73.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoHealth is 0.21x versus 0.79x for CorVel. Usually stocks with elevated PS ratios are considered overvalued.

eHealth has a net margin of 5.73% compared to GoHealth's net margin of -72.72%. GoHealth's return on equity of -6.99% beat eHealth's return on equity of -5.64%.

GoHealth has a consensus price target of --, signalling upside risk potential of 41.83%. On the other hand eHealth has an analysts' consensus of $7.38 which suggests that it could fall by -8.27%. Given that GoHealth has higher upside potential than eHealth, analysts believe GoHealth is more attractive than eHealth.

GoHealth has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison eHealth has a beta of 0.473, suggesting its less volatile than the S&P 500 by 52.725%.

GoHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoHealth pays -5.64% of its earnings as a dividend. eHealth pays out -12.52% of its earnings as a dividend.

GoHealth quarterly revenues are $118.3M, which are larger than eHealth quarterly revenues of $58.4M. GoHealth's net income of $6.8M is higher than eHealth's net income of -$42.5M. Notably, GoHealth's price-to-earnings ratio is -- while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoHealth is 0.21x versus 0.50x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of 5.73% compared to GoHealth's net margin of 17.12%. GoHealth's return on equity of -6.99% beat Kingstone Companies's return on equity of 40.22%.

GoHealth has a consensus price target of --, signalling upside risk potential of 41.83%. On the other hand Kingstone Companies has an analysts' consensus of -- which suggests that it could grow by 9.47%. Given that GoHealth has higher upside potential than Kingstone Companies, analysts believe GoHealth is more attractive than Kingstone Companies.

GoHealth has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.712, suggesting its less volatile than the S&P 500 by 28.819%.

GoHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoHealth pays -5.64% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend.

GoHealth quarterly revenues are $118.3M, which are larger than Kingstone Companies quarterly revenues of $40.8M. GoHealth's net income of $6.8M is lower than Kingstone Companies's net income of $7M. Notably, GoHealth's price-to-earnings ratio is -- while Kingstone Companies's PE ratio is 11.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoHealth is 0.21x versus 1.23x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Reliance Global Group has a net margin of 5.73% compared to GoHealth's net margin of -24.33%. GoHealth's return on equity of -6.99% beat Reliance Global Group's return on equity of -291.14%.

GoHealth has a consensus price target of --, signalling upside risk potential of 41.83%. On the other hand Reliance Global Group has an analysts' consensus of -- which suggests that it could grow by 4603.56%. Given that Reliance Global Group has higher upside potential than GoHealth, analysts believe Reliance Global Group is more attractive than GoHealth.

GoHealth has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Reliance Global Group has a beta of 0.178, suggesting its less volatile than the S&P 500 by 82.159%.

GoHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Reliance Global Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoHealth pays -5.64% of its earnings as a dividend. Reliance Global Group pays out -- of its earnings as a dividend.

GoHealth quarterly revenues are $118.3M, which are larger than Reliance Global Group quarterly revenues of $3.4M. GoHealth's net income of $6.8M is higher than Reliance Global Group's net income of -$837.3K. Notably, GoHealth's price-to-earnings ratio is -- while Reliance Global Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoHealth is 0.21x versus 0.11x for Reliance Global Group. Usually stocks with elevated PS ratios are considered overvalued.